Evidence map›Paper›PMID 12149539›Full record

ReviewThorax2002

"CF asthma": what is it and what do we do about it?

I M Balfour-Lynn, J S Elborn

Abstract readReview
In one paragraph

Review in Thorax, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Short-acting inhaled bronchodilators for cystic fibrosis.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Inhaled corticosteroids for cystic fibrosis.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Long-acting inhaled bronchodilators for cystic fibrosis.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Novel therapeutic approaches for the management of cystic fibrosis.Multidisciplinary respiratory medicine · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Observational
  17. Association of CFTR gene mutation with bronchial asthma.The Indian journal of medical research · 2012
    Review
  18. Article
  19. Article
  20. Asthma in cystic fibrosis.Journal of the Royal Society of Medicine · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

I M Balfour-LynnDepartment of Paediatric Respiratory Medicine, Royal Brompton & Harefield NHS Trust, London SW3 6NP, UK. i.balfourlynn@ic.ac.uk
J S Elborn

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of "CF asthma" is problematic and it is difficult to determine which patients have a combination of CF and asthma and which have asthma like symptoms caused by inflammation of the CF lung. This may not matter, however; the relevance lies in the possible approaches to treatment.

Indexed as

Adrenal Cortex HormonesAdrenergic beta-AntagonistsAsthmaBronchial HyperreactivityBronchodilator AgentsCystic FibrosisDiagnosis, DifferentialExercise TestGastroesophageal RefluxHumansHypersensitivity, ImmediateLeukotriene AntagonistsLung DiseasesPneumoniaRespiratory SoundsSkin TestsAdrenal Cortex HormonesAdrenergic beta-AntagonistsBronchodilator AgentsLeukotriene AntagonistsTheophylline

Identifiers

PMID12149539
PMCPMC1746393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.